AZD-0156

CAS No. 1821428-35-6

AZD-0156( AZD0156 | AZD 0156 )

Catalog No. M12809 CAS No. 1821428-35-6

AZD-0156 (AZD0156, AZD 0156) is a potent, highly selective and orally bioavailable ATM inhibitor; exhibits antitumoral activity, both reducing tumor burden and preventing tumors from growing in an immunocompetent allograft mouse model of AML.Solid Tumors,Phase 1 Clinical

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 42 In Stock
5MG 68 In Stock
10MG 107 In Stock
25MG 187 In Stock
50MG 305 In Stock
100MG 500 In Stock
200MG Get Quote In Stock
500MG 1070 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AZD-0156
  • Note
    Research use only, not for human use.
  • Brief Description
    AZD-0156 (AZD0156, AZD 0156) is a potent, highly selective and orally bioavailable ATM inhibitor; exhibits antitumoral activity, both reducing tumor burden and preventing tumors from growing in an immunocompetent allograft mouse model of AML.Solid Tumors,Phase 1 Clinical
  • Description
    AZD-0156 (AZD0156, AZD 0156) is a potent, highly selective and orally bioavailable ATM inhibitor; exhibits antitumoral activity, both reducing tumor burden and preventing tumors from growing in an immunocompetent allograft mouse model of AML.Solid Tumors Phase 1 Clinical(In Vitro):AZD0156 inhibits the kinase activity of ATM and ATM-mediated signaling, prevents DNA damage checkpoint activation, and disrupts DNA damage repair, inducs tumor cell apoptosis, and leads to cell death in ATM-overexpressing tumor cells.
  • In Vitro
    AZD0156 inhibits the kinase activity of ATM and ATM-mediated signaling, prevents DNA damage checkpoint activation, and disrupts DNA damage repair, inducs tumor cell apoptosis, and leads to cell death in ATM-overexpressing tumor cells.
  • In Vivo
    ——
  • Synonyms
    AZD0156 | AZD 0156
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ATM/ATR
  • Recptor
    ATM
  • Research Area
    Cancer
  • Indication
    Solid Tumors

Chemical Information

  • CAS Number
    1821428-35-6
  • Formula Weight
    461.556
  • Molecular Formula
    C26H31N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 6.2 mg/mL (Need ultrasonic and warming)
  • SMILES
    O=C(N1C2CCOCC2)N(C)C3=C1C4=CC(C5=CC=C(OCCCN(C)C)N=C5)=CC=C4N=C3
  • Chemical Name
    2H-Imidazo[4,5-c]quinolin-2-one, 8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-1,3-dihydro-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Degorce SL, et al. J Med Chem. 2016 Jul 14;59(13):6281-92. 2. Morgado-Palacin I, et al. Sci Signal. 2016 Sep 13;9(445):ra91.
molnova catalog
related products
  • CBP-93872

    A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint.

  • BAY-1895344

    BAY-1895344 is a potent, selective, orally active ATR inhibitor with low-nanomolar potency; potently inhibits the proliferation of a broad spectrum of human tumor cell lines with mean IC50 of 78 nM; inhibits hydroxyurea-induced H2AX phosphorylation, exhibits strong in vivo anti-tumor efficacy in monotherapy in a variety of xenograft models.Blood Cancer,Phase 1 Clinical

  • AZ-31

    A potent, highly selective and orally active ATM inhibitor with enzyme IC50 of <1.2 nM, cell IC50 of 46 nM.